Prenatal exposure to GLP-1 receptor agonists may not pose greater risk than insulin
Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during...
top of page
Browse by category
Search
Browse by tag
bottom of page